In silico identification of SARS-CoV-2 spike (S) protein–ACE2 complex inhibitors from eight Tecoma species and cultivars analyzed by LC-MS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In silico identification of SARS-CoV-2 spike (S) protein–ACE2 complex inhibitors from eight Tecoma species and cultivars analyzed by LC-MS

Published:2020 Issue:70 Volume:10 Page:43103-43108
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

El Hawary Seham S.¹²³⁴,Khattab Amira R.¹⁵⁶⁷⁴^ORCID,Marzouk Hanan S.¹²⁸⁴,El Senousy Amira S.¹²³⁴,Alex Mariam G. A.¹²⁸⁴,Aly Omar M.⁹²¹⁰¹¹⁴,Teleb Mohamed¹²²¹³¹⁴⁴,Abdelmohsen Usama Ramadan¹²¹⁵¹⁶⁴^ORCID

Affiliation:

1. Pharmacognosy Department

2. Faculty of Pharmacy

3. Cairo University

4. Egypt

5. College of Pharmacy

6. Arab Academy for Science, Technology and Maritime Transport

7. Alexandria 1029

8. Pharos University in Alexandria

9. Medicinal Chemistry Department

10. Minia University

11. Minia

12. Department of Pharmaceutical Chemistry

13. Alexandria University

14. Alexandria

15. Deraya University

16. Minia 61111

Abstract

In silico exploration of 12 Tecoma phytocompounds that could serve as potential inhibitors of SARS-CoV entry to host cells.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA08997D

Reference32 articles.

1. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

2. Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale

3. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

4. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

5. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review;Journal of Pharmacy and Pharmacology;2024-07-17

2. Hesperidin, a Potential Antiviral Agent against SARS-CoV-2: The Influence of Citrus Consumption on COVID-19 Incidence and Severity in China;Medicina;2024-05-28

3. Natural products as a source of Coronavirus entry inhibitors;Frontiers in Cellular and Infection Microbiology;2024-02-21

4. Antioxidant and anticancer potential of ethyl acetate extract of bark and flower of Tecoma stans (Linn) and In Silico studies on phytoligands against Bcl 2 and VEGFR2 factors;Environmental Research;2023-08

5. Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential;European Journal of Medicinal Chemistry;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3